Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Rebecca Small, et al v. AMGN, et al
Case Number:
17-11440
Court:
Nature of Suit:
4365 Personal Injury-Product Liability
Companies
Sectors & Industries:
-
February 13, 2018
11th Circ. Asked To Rehear Amgen, Pfizer Win In Enbrel Suit
The Eleventh Circuit failed to consider several issues when it ruled in favor of Amgen Inc., Pfizer Inc. and Wyeth Inc. in a lawsuit brought by a woman claiming their arthritis drug, Enbrel, caused severe infections, according to a motion for rehearing filed Monday.
-
January 22, 2018
11th Circ. Upholds Amgen, Pfizer Win In Infection Suit
The Eleventh Circuit affirmed on Monday a lower court's decision to grant Amgen Inc., Pfizer Inc. and Wyeth Inc. a quick win in a suit alleging their arthritis drug Enbrel caused a woman severe infections, finding the woman's doctor knew about the drug's risks, so she can't claim the drugmakers didn't warn her.